StemCells, Inc. Completes Enrollment in Spinal Cord Injury Trial
April 17, 2014 at 08:02 AM EDT
StemCells, Inc. (Nasdaq: STEM) announced today that it has completed enrollment in the Company's Phase I/II clinical trial in spinal ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.